Showing 181 - 200 results of 393 for search '"Multiple sclerosis"', query time: 0.10s Refine Results
  1. 181

    Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis by P. P. Sainaghi, L. Collimedaglia, F. Alciato, R. Molinari, D. Sola, E. Ranza, P. Naldi, F. Monaco, M. Leone, M. Pirisi, G. C. Avanzi

    Published 2013-01-01
    “…Therefore, we aimed to verify whether cerebrospinal-fluid (CSF) Gas6 concentration may represent a biomarker of disease activity in multiple sclerosis. Methods. Sixty-five patients who underwent a spinal tap during relapse of relapsing/remitting multiple sclerosis (RR-MS)(McDonald-criteria) were studied. …”
    Get full text
    Article
  2. 182

    The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis by O. Mirmosayyeb, V. Shaygannejad, N. Ebrahimi, H. Ghoshouni, M. Ghajarzadeh

    Published 2025-01-01
    “…Objective: To estimate the pooled prevalence of cancer in patients with multiple sclerosis (MS) cases who were under treatment with rituximab. …”
    Get full text
    Article
  3. 183

    FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis by David Hunt, Siddharthan Chandran, Peter Connick, Peter Foley, Patrick K A Kearns, Sergio E Baranzini, Adam D Waldman, Sarah J Martin, Elizabeth Freyer, F J Carod-Artal, Lee Murphy, Amy Stenson, Jessie Chang, Rozanna Meijboom, Elizabeth N York, Yingdi Chen, Christine Weaver, Katarzyna Hafezi, Stacey Thomson, Adil Harroud, Margaret McLeod, Jonathon O'Riordan, Niall J J MacDougall

    Published 2022-06-01
    “…Purpose Multiple sclerosis (MS) is an immune-mediated, neuroinflammatory disease of the central nervous system and in industrialised countries is the most common cause of progressive neurological disability in working age persons. …”
    Get full text
    Article
  4. 184

    Assessment and Management of Cognitive and Psychosocial Difficulties for People with Multiple Sclerosis in Ireland: A National Survey of Clinical Practice by Sinéad M. Hynes, Fiadhnait O’Keeffe, Eimear Bane, Megan H. Oglesby, Christopher P. Dwyer, Robert Joyce, Olga A. Klein

    Published 2022-01-01
    “…A recent survey of 109 healthcare professionals explored how UK healthcare professionals typically assess and treat multiple sclerosis (MS)-related cognitive impairment. Little is currently known about what constitutes usual care for cognitive impairment and psychosocial care for people with MS in Ireland. …”
    Get full text
    Article
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192

    Smoking habits, awareness and support needs for cessation among people with multiple sclerosis in Australia: findings from an online survey by Roshan das Nair, Ron Borland, Claudia H Marck, Isabelle Weld-Blundell, Lisa Grech, Sarah L White

    Published 2022-07-01
    “…Objectives To assess smoking habits, nicotine use, exposure to passive smoking, awareness of associated harms, and experiences with and preferences for smoking cessation support among people with multiple sclerosis (MS).Design Online survey, convenience sampling.Setting Community setting, Australia.Participants Adults living in Australia with probable or diagnosed MS were recruited via social media and newsletters to participate in 2020.Results Of the 284 participants in our convenience sample, 25.7% were current smokers (n=73) and 38.0% were former smokers (n=108). …”
    Get full text
    Article
  13. 193

    Repeat Intrathecal Triamcinolone Acetonide Application Reduces Acute Occurring Painful Dysesthesia in Patients with Relapsing Remitting Multiple Sclerosis by Kerstin Hellwig, Carsten Lukas, Niels Brune, Volker Hoffmann, Sebastian Schimrigk, Horst Przuntek, Thomas Müller

    Published 2006-01-01
    “…We describe four patients with relapsing remitting multiple sclerosis (RRMS) who experienced a relapse with acute onset of painful sensations. …”
    Get full text
    Article
  14. 194

    Adverse Reactions due to the Usage Ofadverse Effects due to the Usage of T biomodulina and corticotropin in Patients Suffering from Multiple Sclerosis by Rosa F. Lara Rodríguez, Roman Rodríguez, Alicia Vargas Batista, Miriam Bolet Arostavista, Rebeca A. Fernández Carriera, Idalmis Suárez Luis, Alina González-Quevedo Monteagudo, Lorenzo Gómez Morales

    Published 2007-05-01
    “…Corticotropin is a steroid which is also used in the treatment of multiple sclerosis. <strong>Objetives:</strong> To compare the adverse effects of the biomodulina and corticotroprin in the treatment of multiple sclerosis. …”
    Get full text
    Article
  15. 195

    Evaluation of Retinal Structure and Optic Nerve Function Changes in Multiple Sclerosis: Longitudinal Study with 1-Year Follow-Up by Riwanti Estiasari, Adisresti Diwyacitta, Muhammad Sidik, Ni Nengah Rida Ariarini, Freddy Sitorus, Saraf Shafa Marwadhani, Kartika Maharani, Darma Imran, Reza Aditya Arpandy, David Pangeran, Manfaluthy Hakim

    Published 2021-01-01
    “…Background. Multiple sclerosis (MS) is an autoimmune disease characterized by inflammation and demyelination of the central nervous system which often involves the optic nerve even though only 20% of the patients experience optic neuritis (ON). …”
    Get full text
    Article
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200

    Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population by Dingwei Dai, Ajay Sharma, Amy L. Phillips, Carroline Lobo

    Published 2022-11-01
    “…**Background:** Comorbidities are common in patients with multiple sclerosis (MS), thus increasing the complexity of disease management and economic burden and worsening their prognosis and quality of life. …”
    Get full text
    Article